BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $514,075 (94.8% shares, 5.2% debt)

Holdings (31)

IRWD IRONWOOD PHARMACEUTICALS INC 15.2%

Value ($000) $78,037 Shares 5,093,810 Est. Cost $10.93 Unrealized +4.7%

— CHEMOCENTRYX INC 11.4%

Value ($000) $58,716 Shares 8,596,772 Est. Cost $10.60 Unrealized —

— ARRAY BIOPHARMA INC 10.8%

Value ($000) $55,683 Shares 11,772,335 Est. Cost $4.56 Unrealized —

LGND LIGAND PHARMACEUTICALS INC 8.9%

Value ($000) $45,764 Shares 860,063 Est. Cost $17.99 Unrealized +80.9%

— ONCOMED PHARMACEUTICALS INC 5.8%

Value ($000) $29,916 Shares 1,374,815 Est. Cost $22.40 Unrealized —

— ONCOTHYREON INC 5.1%

Value ($000) $26,148 Shares 13,762,260 Est. Cost $1.79 Unrealized —

— FIVE PRIME THERAPEUTICS INC 4.3%

Value ($000) $22,311 Shares 826,332 Est. Cost $17.29 Unrealized —

— FORWARD PHARMA A/S 4.3%

Value ($000) $21,921 Shares 1,052,381 Est. Cost $20.83 Unrealized —

CYTK CYTOKINETICS INC 3.8%

Value ($000) $19,569 Shares 2,443,100 Est. Cost $5.41 Unrealized -20.7%

— EXELIXIS INC 3.5%

Value ($000) $18,093 Shares 31,239,000 Est. Cost $0.79 Unrealized —

— TARGACEPT INC 3.4%

Value ($000) $17,503 Shares 6,655,128 Est. Cost $4.29 Unrealized —

— CONCERT PHARMACEUTICALS INC 3.1%

Value ($000) $16,070 Shares 1,206,459 Est. Cost $12.61 Unrealized —

— LOXO ONCOLOGY INC 2.7%

Value ($000) $13,991 Shares 1,190,702 Est. Cost $13.13 Unrealized —

— VITAE PHARMACEUTICALS INC 2.4%

Value ($000) $12,545 Shares 753,935 Est. Cost $8.68 Unrealized —

XENE XENON PHARMACEUTICALS INC 2.4%

Value ($000) $12,210 Shares 618,224 Est. Cost $14.68 Unrealized 0.0%

— QLT INC 2.1%

Value ($000) $10,629 Shares 2,650,563 Est. Cost $4.31 Unrealized —

— ARRAY BIOPHARMA INC 1.6%

Value ($000) $8,477 Shares 9,000,000 Est. Cost $0.98 Unrealized —

— GTX INC DEL 1.6%

Value ($000) $8,111 Shares 11,111,111 Est. Cost $0.73 Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.6%

Value ($000) $7,997 Shares 3,136,000 Est. Cost $2.55 Unrealized —

EXEL EXELIXIS INC 1.2%

Value ($000) $6,041 Shares 4,195,352 Est. Cost $1.56 Unrealized 0.0%

— ARQULE INC 1.1%

Value ($000) $5,763 Shares 4,723,811 Est. Cost $1.81 Unrealized —

— MAST THERAPEUTICS INC 0.8%

Value ($000) $4,083 Shares 7,291,600 Est. Cost $0.56 Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.6%

Value ($000) $3,134 Shares 1,368,500 Est. Cost $2.99 Unrealized —

— BIOLINERX LTD 0.5%

Value ($000) $2,432 Shares 1,501,000 Est. Cost $2.16 Unrealized —

— KALOBIOS PHARMACEUTICALS INC 0.4%

Value ($000) $2,010 Shares 1,162,000 Est. Cost $2.28 Unrealized —

— ACHAOGEN INC 0.3%

Value ($000) $1,783 Shares 136,600 Est. Cost $14.91 Unrealized —

— REGADO BIOSCIENCES INC 0.3%

Value ($000) $1,719 Shares 1,882,521 Est. Cost $6.73 Unrealized —

— APTOSE BIOSCIENCES INC 0.2%

Value ($000) $986 Shares 166,664 Est. Cost $5.92 Unrealized —

— BIOTA PHARMACEUTIALS INC 0.2%

Value ($000) $976 Shares 435,900 Est. Cost $6.11 Unrealized —

— ANTHERA PHARMACEUTICALS INC 0.2%

Value ($000) $884 Shares 559,624 Est. Cost $4.02 Unrealized —

— SOPHIRIS BIO INC 0.1%

Value ($000) $573 Shares 1,060,283 Est. Cost $2.88 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	5,093,810	$78,037	15.2%	$10.93	+4.7%	COM CL A	46333X108
—	CHEMOCENTRYX INC	8,596,772	$58,716	11.4%	$10.60	—	COM	16383L106
—	ARRAY BIOPHARMA INC	11,772,335	$55,683	10.8%	$4.56	—	COM	04269X105
LGND	LIGAND PHARMACEUTICALS INC	860,063	$45,764	8.9%	$17.99	+80.9%	COM NEW	53220K504
—	ONCOMED PHARMACEUTICALS INC	1,374,815	$29,916	5.8%	$22.40	—	COM	68234X102
—	ONCOTHYREON INC	13,762,260	$26,148	5.1%	$1.79	—	COM	682324108
—	FIVE PRIME THERAPEUTICS INC	826,332	$22,311	4.3%	$17.29	—	COM	33830X104
—	FORWARD PHARMA A/S	1,052,381	$21,921	4.3%	$20.83	—	SPONSORED ADR	34986J105
CYTK	CYTOKINETICS INC	2,443,100	$19,569	3.8%	$5.41	-20.7%	COM NEW	23282W605
—	EXELIXIS INC	31,239,000	$18,093	3.5%	$0.79	—	NOTE 4.250% 8/1	30161QAC8
—	TARGACEPT INC	6,655,128	$17,503	3.4%	$4.29	—	COM	87611R306
—	CONCERT PHARMACEUTICALS INC	1,206,459	$16,070	3.1%	$12.61	—	COM	206022105
—	LOXO ONCOLOGY INC	1,190,702	$13,991	2.7%	$13.13	—	COM	548862101
—	VITAE PHARMACEUTICALS INC	753,935	$12,545	2.4%	$8.68	—	COM	92847N103
XENE	XENON PHARMACEUTICALS INC	618,224	$12,210	2.4%	$14.68	0.0%	COM	98420N105
—	QLT INC	2,650,563	$10,629	2.1%	$4.31	—	COM	746927102
—	ARRAY BIOPHARMA INC	9,000,000	$8,477	1.6%	$0.98	—	NOTE 3.000% 06/0	04269XAA3
—	GTX INC DEL	11,111,111	$8,111	1.6%	$0.73	—	COM	40052B108
—	SUNESIS PHARMACEUTICALS INC	3,136,000	$7,997	1.6%	$2.55	—	COM NEW	867328601
EXEL	EXELIXIS INC	4,195,352	$6,041	1.2%	$1.56	0.0%	COM	30161Q104
—	ARQULE INC	4,723,811	$5,763	1.1%	$1.81	—	COM	04269E107
—	MAST THERAPEUTICS INC	7,291,600	$4,083	0.8%	$0.56	—	COM	576314108
—	ONCOGENEX PHARMACEUTICALS IN	1,368,500	$3,134	0.6%	$2.99	—	COM	68230A106
—	BIOLINERX LTD	1,501,000	$2,432	0.5%	$2.16	—	SPONSORED ADR	09071M106
—	KALOBIOS PHARMACEUTICALS INC	1,162,000	$2,010	0.4%	$2.28	—	COM	48344T100
—	ACHAOGEN INC	136,600	$1,783	0.3%	$14.91	—	COM	004449104
—	REGADO BIOSCIENCES INC	1,882,521	$1,719	0.3%	$6.73	—	COM	75874Q107
—	APTOSE BIOSCIENCES INC	166,664	$986	0.2%	$5.92	—	COM NEW	03835T200
—	BIOTA PHARMACEUTIALS INC	435,900	$976	0.2%	$6.11	—	COM	090694100
—	ANTHERA PHARMACEUTICALS INC	559,624	$884	0.2%	$4.02	—	COM NEW	03674U201
—	SOPHIRIS BIO INC	1,060,283	$573	0.1%	$2.88	—	COM NEW	83578Q209